glp 1 agonist small molecule GLP-1 agonists Media Centre | EASD

These findings reinforce the at-risk status as a contraindication to GLP-1RA treatment, but given their low incidence, screening measures to facilitate early diagnosis of medullary thyroid carcinomas in GLP-1RAtreated individuals have not been established

10.1038/s41591-024-03355-2 [DOI] [PMC free article] [PubMed] [Google Scholar] 68.Cui SS, Feng XB, Zhang BH, Xia ZY, Zhan LY (2020) Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation

Start low, monitor closely, and adjust: Change dose or switch medicine if side effects or inadequate response occur

510% weight loss is considered clinically meaningful with pharmacotherapy

INTRODUCTION Glucagonlike peptide1 (GLP1) receptor agonists (GLP1RAs) are an established treatment for type 2 diabetes (T2D)

Stop-or-not trial group